Commonly used methods for patient screening include determination of PD-L1 expression, MSI assay, tumor mutational load (TMB) assay, and tumor-infiltrating lymphocyte (TIL) assay; however, their operations are complicated with a low accuracy [11]. The gene discussed is CD274; the disease is neoplasm.